Proteome Sciences plc (PMSNF)
OTCMKTS · Delayed Price · Currency is USD
0.0449
-0.0051 (-10.20%)
At close: Jun 17, 2025
Proteome Sciences Revenue
In the year 2024, Proteome Sciences had annual revenue of 4.89M GBP, down -2.80%. Proteome Sciences had revenue of 2.67M in the half year ending December 31, 2024, a decrease of -41.15%.
Revenue
4.89M GBP
Revenue Growth
-2.80%
P/S Ratio
2.27
Revenue / Employee
135.75K GBP
Employees
36
Market Cap
13.86M USD
Revenue Chart
* This company reports financials in GBP.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.89M | -141.00K | -2.80% |
| Dec 31, 2023 | 5.03M | -2.75M | -35.37% |
| Dec 31, 2022 | 7.78M | 2.65M | 51.69% |
| Dec 31, 2021 | 5.13M | 376.00K | 7.91% |
| Dec 31, 2020 | 4.75M | 97.00K | 2.08% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 105.45M |
| Tian'an Technology Group | 2.12M |
| Glass House Brands | 221.55M |
| Northwest Biotherapeutics | 1.09M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.17M |
| Longduoduo Company | 4.99M |
Proteome Sciences News
- 2 months ago - AIM Market Roundup: Seascape Energy, Earnz, Directa Plus - The Armchair Trader
- 6 months ago - AIM Market Roundup: Proteome Sciences, UKRProduct, Staffline - The Armchair Trader